Alterations to the Hidradenitis Suppurativa Serum Proteome with Spleen Tyrosine Kinase Antagonism: Proteomic Results from a Phase 2 Clinical Trial.. Alterations to the Hidradenitis Suppurativa Serum Proteome with Spleen Tyrosine Kinase Antagonism: Proteomic Results from a Phase 2 Clinical Trial.
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1004299
下载链接
链接失效反馈官方服务：
资源简介：
Serum Proteomic Analysis of patients with Hidradenitis Suppurativa treated with Fostamatinib Overall design: Phase 2 Clinical Trial (NCT05040698)
创建时间：
2023-08-10
